ESR1 and neoplasm: The effect can be modulated in an independent manner or in combination with other targeted therapy.[17] Some literature suggests that a tumor with high AR blocks and deregulates ERα expression and promotes metastasis, and endocrine resistance by epigenetically modifying E-cadherin and vimentin expression.